WILLIAM J. NEWELL - 30 Dec 2021 Form 4 Insider Report for SUTRO BIOPHARMA, INC. (STRO)

Role
CEO, Director
Signature
/s/ Edward C. Albini as attorney-in-fact for William Newell
Issuer symbol
STRO
Transactions as of
30 Dec 2021
Net transactions value
$0
Form type
4
Filing time
03 Jan 2022, 17:28:01 UTC
Previous filing
28 Sep 2021
Next filing
01 Feb 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction STRO Common Stock Other $0 -26,091 -100% $0.000000* 0 30 Dec 2021 By Taluswood Partners, L.P. F1, F2
transaction STRO Common Stock Other $0 +1,863 +1.8% $0.000000 106,525 30 Dec 2021 By William J. Newell Family Trust DTD 03/15/2019 F3, F4
holding STRO Common Stock 92,721 30 Dec 2021 Direct
holding STRO Common Stock 10,577 30 Dec 2021 By Newell Family Revocable Trust DTD 08/14/2008 F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents pro rata distributions to the limited partners of Taluswood Partners, L.P. ("Taluswood").
F2 The reporting person is the general partner of Taluswood. The reporting person disclaims beneficial ownership over such securities except to the extent of his pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of the reported securities for purposes of Section 16 or for any other purposes.
F3 Represents shares received as a liquidating distribution from Taluswood.
F4 The securities are held of record by the reporting person as trustee of the William J. Newell Family Trust DTD 03/15/2019.
F5 The securities are held of record by the reporting person as trustee of the Newell Family Revocable Trust DTD 08/14/2008.